nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—PRUNE—liver—bile duct cancer	0.0168	0.0528	CbGeAlD
Dipyridamole—PDE6D—liver—bile duct cancer	0.0163	0.051	CbGeAlD
Dipyridamole—PDE11A—liver—bile duct cancer	0.0149	0.0466	CbGeAlD
Dipyridamole—PDE6G—liver—bile duct cancer	0.0143	0.0449	CbGeAlD
Dipyridamole—PDE1C—lymph node—bile duct cancer	0.0143	0.0449	CbGeAlD
Dipyridamole—PDE3B—pancreas—bile duct cancer	0.0142	0.0444	CbGeAlD
Dipyridamole—PDE8A—pancreas—bile duct cancer	0.013	0.0409	CbGeAlD
Dipyridamole—PRUNE—lymph node—bile duct cancer	0.0129	0.0405	CbGeAlD
Dipyridamole—PDE6D—lymph node—bile duct cancer	0.0125	0.0391	CbGeAlD
Dipyridamole—PDE7B—liver—bile duct cancer	0.0116	0.0363	CbGeAlD
Dipyridamole—PDE6G—lymph node—bile duct cancer	0.011	0.0344	CbGeAlD
Dipyridamole—PDE2A—liver—bile duct cancer	0.00967	0.0303	CbGeAlD
Dipyridamole—PDE8B—liver—bile duct cancer	0.00922	0.0289	CbGeAlD
Dipyridamole—PDE3B—liver—bile duct cancer	0.00901	0.0282	CbGeAlD
Dipyridamole—PDE7B—lymph node—bile duct cancer	0.00888	0.0278	CbGeAlD
Dipyridamole—PDE8A—liver—bile duct cancer	0.0083	0.026	CbGeAlD
Dipyridamole—PDE1A—liver—bile duct cancer	0.00803	0.0252	CbGeAlD
Dipyridamole—SLC29A1—pancreas—bile duct cancer	0.00747	0.0234	CbGeAlD
Dipyridamole—PDE2A—lymph node—bile duct cancer	0.00741	0.0232	CbGeAlD
Dipyridamole—PDE10A—lymph node—bile duct cancer	0.00741	0.0232	CbGeAlD
Dipyridamole—PDE1B—lymph node—bile duct cancer	0.00735	0.023	CbGeAlD
Dipyridamole—PDE8B—lymph node—bile duct cancer	0.00707	0.0222	CbGeAlD
Dipyridamole—PDE3B—lymph node—bile duct cancer	0.00691	0.0217	CbGeAlD
Dipyridamole—PDE8A—lymph node—bile duct cancer	0.00636	0.0199	CbGeAlD
Dipyridamole—PDE1A—lymph node—bile duct cancer	0.00616	0.0193	CbGeAlD
Dipyridamole—ABCC4—pancreas—bile duct cancer	0.00564	0.0177	CbGeAlD
Dipyridamole—PDE3A—liver—bile duct cancer	0.0055	0.0173	CbGeAlD
Dipyridamole—ADA—lymph node—bile duct cancer	0.00524	0.0164	CbGeAlD
Dipyridamole—ABCC5—liver—bile duct cancer	0.00517	0.0162	CbGeAlD
Dipyridamole—PDE4A—lymph node—bile duct cancer	0.0051	0.016	CbGeAlD
Dipyridamole—SLC29A1—liver—bile duct cancer	0.00475	0.0149	CbGeAlD
Dipyridamole—PDE5A—lymph node—bile duct cancer	0.00434	0.0136	CbGeAlD
Dipyridamole—PDE3A—lymph node—bile duct cancer	0.00422	0.0132	CbGeAlD
Dipyridamole—ABCC5—lymph node—bile duct cancer	0.00397	0.0124	CbGeAlD
Dipyridamole—SLC29A1—lymph node—bile duct cancer	0.00364	0.0114	CbGeAlD
Dipyridamole—ABCC4—liver—bile duct cancer	0.00359	0.0112	CbGeAlD
Dipyridamole—ABCC4—lymph node—bile duct cancer	0.00275	0.00862	CbGeAlD
Dipyridamole—ABCB1—pancreas—bile duct cancer	0.00196	0.00615	CbGeAlD
Dipyridamole—ABCB1—liver—bile duct cancer	0.00125	0.00391	CbGeAlD
Dipyridamole—ABCB1—lymph node—bile duct cancer	0.000957	0.003	CbGeAlD
Dipyridamole—PDE3A—Signaling Pathways—SMAD4—bile duct cancer	0.000209	0.000307	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NOS2—bile duct cancer	0.000209	0.000307	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NOS2—bile duct cancer	0.000209	0.000307	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—TGFB1—bile duct cancer	0.000208	0.000306	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFBR2—bile duct cancer	0.000208	0.000305	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—KRAS—bile duct cancer	0.000207	0.000304	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—KRAS—bile duct cancer	0.000207	0.000304	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—ERBB2—bile duct cancer	0.000206	0.000303	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—TGFB1—bile duct cancer	0.000206	0.000302	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MMP9—bile duct cancer	0.000205	0.000302	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—NRAS—bile duct cancer	0.000204	0.0003	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—NRAS—bile duct cancer	0.000204	0.0003	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—EGFR—bile duct cancer	0.000204	0.0003	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—ERBB2—bile duct cancer	0.000204	0.000299	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—NRAS—bile duct cancer	0.000203	0.000298	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—EGFR—bile duct cancer	0.000202	0.000297	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—EGFR—bile duct cancer	0.000202	0.000296	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—IL6—bile duct cancer	0.000201	0.000295	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—IL6—bile duct cancer	0.000201	0.000295	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TP53—bile duct cancer	0.000201	0.000295	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—GNAS—bile duct cancer	0.0002	0.000294	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—NRAS—bile duct cancer	0.000199	0.000292	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—ERBB2—bile duct cancer	0.000198	0.000291	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SMAD4—bile duct cancer	0.000196	0.000288	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—HRAS—bile duct cancer	0.000194	0.000286	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.000194	0.000285	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—KRAS—bile duct cancer	0.000194	0.000285	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—KRAS—bile duct cancer	0.000193	0.000283	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—HRAS—bile duct cancer	0.000192	0.000282	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—KRAS—bile duct cancer	0.000191	0.000281	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NOS2—bile duct cancer	0.000191	0.00028	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MMP9—bile duct cancer	0.000191	0.00028	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MMP9—bile duct cancer	0.000191	0.00028	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—KRAS—bile duct cancer	0.00019	0.00028	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.00019	0.000279	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TGFB1—bile duct cancer	0.00019	0.000279	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TGFB1—bile duct cancer	0.00019	0.000279	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFBR2—bile duct cancer	0.00019	0.000279	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TP53—bile duct cancer	0.000189	0.000277	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—HRAS—bile duct cancer	0.000187	0.000275	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—EGFR—bile duct cancer	0.000186	0.000273	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—EGFR—bile duct cancer	0.000186	0.000273	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL6—bile duct cancer	0.000186	0.000273	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—EGFR—bile duct cancer	0.000185	0.000272	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TGFB1—bile duct cancer	0.000185	0.000272	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—bile duct cancer	0.000184	0.00027	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—bile duct cancer	0.000184	0.00027	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—GNAS—bile duct cancer	0.000183	0.000269	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—NRAS—bile duct cancer	0.000182	0.000268	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—EGFR—bile duct cancer	0.000181	0.000266	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000181	0.000265	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—HRAS—bile duct cancer	0.00018	0.000265	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SMAD4—bile duct cancer	0.00018	0.000264	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL6—bile duct cancer	0.000179	0.000263	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—HRAS—bile duct cancer	0.000178	0.000261	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MMP9—bile duct cancer	0.000177	0.00026	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PTGS2—bile duct cancer	0.000177	0.00026	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—KRAS—bile duct cancer	0.000176	0.000258	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—KRAS—bile duct cancer	0.000176	0.000258	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—HRAS—bile duct cancer	0.000176	0.000258	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—HRAS—bile duct cancer	0.000176	0.000258	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—KRAS—bile duct cancer	0.000175	0.000257	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MMP9—bile duct cancer	0.000175	0.000256	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—bile duct cancer	0.000173	0.000253	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—KRAS—bile duct cancer	0.000171	0.000252	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—NRAS—bile duct cancer	0.000171	0.000251	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MMP9—bile duct cancer	0.00017	0.00025	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—ERBB2—bile duct cancer	0.00017	0.00025	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL6—bile duct cancer	0.00017	0.00025	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—NRAS—bile duct cancer	0.000169	0.000249	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—NRAS—bile duct cancer	0.000169	0.000249	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TGFB1—bile duct cancer	0.000169	0.000249	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL6—bile duct cancer	0.000168	0.000247	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL6—bile duct cancer	0.000168	0.000247	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—EGFR—bile duct cancer	0.000166	0.000244	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—NRAS—bile duct cancer	0.000165	0.000243	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—HRAS—bile duct cancer	0.000165	0.000242	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—HRAS—bile duct cancer	0.000164	0.000241	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—HRAS—bile duct cancer	0.000162	0.000239	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—HRAS—bile duct cancer	0.000162	0.000238	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TGFB1—bile duct cancer	0.000159	0.000233	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TGFB1—bile duct cancer	0.000157	0.000231	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TGFB1—bile duct cancer	0.000157	0.000231	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—NRAS—bile duct cancer	0.000157	0.000231	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—ERBB2—bile duct cancer	0.000157	0.000231	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—ERBB2—bile duct cancer	0.000157	0.000231	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—IL6—bile duct cancer	0.000157	0.000231	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—KRAS—bile duct cancer	0.000157	0.00023	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—bile duct cancer	0.000156	0.00023	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—bile duct cancer	0.000156	0.00023	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—IL6—bile duct cancer	0.000156	0.000228	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ERBB2—bile duct cancer	0.000156	0.000228	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—NRAS—bile duct cancer	0.000155	0.000227	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—IL6—bile duct cancer	0.000155	0.000227	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—NRAS—bile duct cancer	0.000155	0.000227	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—EGFR—bile duct cancer	0.000154	0.000227	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—EGFR—bile duct cancer	0.000154	0.000227	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTGS2—bile duct cancer	0.000154	0.000225	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTGS2—bile duct cancer	0.000154	0.000225	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—bile duct cancer	0.000152	0.000224	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—NRAS—bile duct cancer	0.000151	0.000222	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—EGFR—bile duct cancer	0.000151	0.000221	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—NRAS—bile duct cancer	0.000151	0.000221	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—HRAS—bile duct cancer	0.00015	0.00022	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—HRAS—bile duct cancer	0.00015	0.00022	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—IDH2—bile duct cancer	0.000149	0.000219	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—HRAS—bile duct cancer	0.000149	0.000218	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—KRAS—bile duct cancer	0.000147	0.000216	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TGFB1—bile duct cancer	0.000146	0.000214	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—KRAS—bile duct cancer	0.000146	0.000214	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—KRAS—bile duct cancer	0.000146	0.000214	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—HRAS—bile duct cancer	0.000146	0.000214	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TGFB1—bile duct cancer	0.000144	0.000211	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—ERBB2—bile duct cancer	0.000144	0.000211	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL6—bile duct cancer	0.000143	0.00021	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL6—bile duct cancer	0.000143	0.00021	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EGFR—bile duct cancer	0.000143	0.00021	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—KRAS—bile duct cancer	0.000142	0.000209	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—IL6—bile duct cancer	0.000142	0.000209	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—NRAS—bile duct cancer	0.000142	0.000208	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EGFR—bile duct cancer	0.000141	0.000207	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—EGFR—bile duct cancer	0.000141	0.000207	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00014	0.000206	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTGS2—bile duct cancer	0.00014	0.000206	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TGFB1—bile duct cancer	0.00014	0.000206	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL6—bile duct cancer	0.000139	0.000205	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—bile duct cancer	0.000139	0.000205	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EGFR—bile duct cancer	0.000138	0.000202	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000137	0.000202	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—EGFR—bile duct cancer	0.000137	0.000201	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—KRAS—bile duct cancer	0.000135	0.000198	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000135	0.000198	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—KRAS—bile duct cancer	0.000133	0.000196	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—HRAS—bile duct cancer	0.000133	0.000196	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—KRAS—bile duct cancer	0.000133	0.000196	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—bile duct cancer	0.000131	0.000192	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—KRAS—bile duct cancer	0.00013	0.000191	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—KRAS—bile duct cancer	0.00013	0.00019	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—bile duct cancer	0.00013	0.00019	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—bile duct cancer	0.00013	0.00019	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—NRAS—bile duct cancer	0.00013	0.00019	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—NRAS—bile duct cancer	0.000129	0.00019	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—EGFR—bile duct cancer	0.000129	0.000189	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—bile duct cancer	0.000129	0.000189	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ERBB2—bile duct cancer	0.000128	0.000189	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—IDH1—bile duct cancer	0.000128	0.000188	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—bile duct cancer	0.000128	0.000187	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000127	0.000187	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—HRAS—bile duct cancer	0.000125	0.000184	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—HRAS—bile duct cancer	0.000124	0.000182	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—HRAS—bile duct cancer	0.000124	0.000182	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—KRAS—bile duct cancer	0.000122	0.000179	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—HRAS—bile duct cancer	0.000121	0.000178	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ERBB2—bile duct cancer	0.00012	0.000177	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—bile duct cancer	0.00012	0.000176	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NRAS—bile duct cancer	0.000119	0.000175	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NRAS—bile duct cancer	0.000119	0.000175	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—bile duct cancer	0.000119	0.000174	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—bile duct cancer	0.000119	0.000174	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—bile duct cancer	0.000118	0.000174	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—NRAS—bile duct cancer	0.000118	0.000174	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—bile duct cancer	0.000118	0.000173	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—bile duct cancer	0.000118	0.000173	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ERBB2—bile duct cancer	0.000117	0.000172	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—bile duct cancer	0.000116	0.00017	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—bile duct cancer	0.000115	0.00017	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—HRAS—bile duct cancer	0.000115	0.000169	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—HRAS—bile duct cancer	0.000113	0.000166	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—HRAS—bile duct cancer	0.000113	0.000166	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000113	0.000166	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—KRAS—bile duct cancer	0.000111	0.000164	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—KRAS—bile duct cancer	0.000111	0.000164	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TGFB1—bile duct cancer	0.000111	0.000163	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TGFB1—bile duct cancer	0.000111	0.000163	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—HRAS—bile duct cancer	0.00011	0.000162	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—HRAS—bile duct cancer	0.00011	0.000162	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—bile duct cancer	0.00011	0.000162	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ERBB2—bile duct cancer	0.00011	0.000161	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—bile duct cancer	0.00011	0.000161	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NRAS—bile duct cancer	0.000109	0.00016	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—bile duct cancer	0.000109	0.00016	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—bile duct cancer	0.000109	0.00016	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—bile duct cancer	0.000108	0.000159	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—bile duct cancer	0.000108	0.000159	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—bile duct cancer	0.000108	0.000158	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—bile duct cancer	0.000106	0.000155	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—bile duct cancer	0.000105	0.000155	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—HRAS—bile duct cancer	0.000104	0.000152	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—bile duct cancer	0.000103	0.000151	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—KRAS—bile duct cancer	0.000103	0.000151	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—KRAS—bile duct cancer	0.000103	0.000151	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—KRAS—bile duct cancer	0.000102	0.00015	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TGFB1—bile duct cancer	0.000102	0.000149	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ERBB2—bile duct cancer	0.000101	0.000148	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—bile duct cancer	0.0001	0.000147	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—bile duct cancer	9.95e-05	0.000146	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—bile duct cancer	9.91e-05	0.000146	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NRAS—bile duct cancer	9.77e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—HRAS—bile duct cancer	9.47e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HRAS—bile duct cancer	9.46e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—bile duct cancer	9.43e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—KRAS—bile duct cancer	9.4e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NRAS—bile duct cancer	9.15e-05	0.000134	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TGFB1—bile duct cancer	9.08e-05	0.000133	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—bile duct cancer	9.07e-05	0.000133	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—bile duct cancer	9.06e-05	0.000133	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—bile duct cancer	8.9e-05	0.000131	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NRAS—bile duct cancer	8.9e-05	0.000131	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HRAS—bile duct cancer	8.74e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HRAS—bile duct cancer	8.74e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HRAS—bile duct cancer	8.66e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—bile duct cancer	8.63e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TGFB1—bile duct cancer	8.5e-05	0.000125	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC5A5—bile duct cancer	8.47e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KRAS—bile duct cancer	8.41e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NRAS—bile duct cancer	8.36e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—bile duct cancer	8.36e-05	0.000123	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—bile duct cancer	8.36e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—bile duct cancer	8.33e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—bile duct cancer	8.29e-05	0.000122	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TGFB1—bile duct cancer	8.27e-05	0.000121	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—bile duct cancer	8.11e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HRAS—bile duct cancer	7.99e-05	0.000117	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KRAS—bile duct cancer	7.87e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFB1—bile duct cancer	7.77e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KRAS—bile duct cancer	7.66e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NRAS—bile duct cancer	7.65e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—bile duct cancer	7.65e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—bile duct cancer	7.62e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—bile duct cancer	7.47e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KRAS—bile duct cancer	7.2e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—HRAS—bile duct cancer	7.15e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFB1—bile duct cancer	7.11e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—bile duct cancer	7e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—bile duct cancer	6.97e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—bile duct cancer	6.84e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—bile duct cancer	6.81e-05	9.99e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HRAS—bile duct cancer	6.69e-05	9.82e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KRAS—bile duct cancer	6.58e-05	9.67e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GNAS—bile duct cancer	6.58e-05	9.66e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HRAS—bile duct cancer	6.51e-05	9.56e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—bile duct cancer	6.4e-05	9.4e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—bile duct cancer	6.4e-05	9.4e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—bile duct cancer	6.23e-05	9.15e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HRAS—bile duct cancer	6.12e-05	8.99e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—bile duct cancer	5.86e-05	8.6e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—bile duct cancer	5.85e-05	8.59e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HRAS—bile duct cancer	5.6e-05	8.22e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—bile duct cancer	5.36e-05	7.87e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—bile duct cancer	3.53e-05	5.19e-05	CbGpPWpGaD
